Clinical Trial Update: Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating GSK961081 and Fluticasone Furoate when given alone or in combination in chronic obstructive pulmonary disease. The tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone Furoate (fluticasone furoate)
• GSK961081

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED